Comparison

Dorsomorphin (dihydrochloride) European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Clone N/A
Amount 10mM/1mL
Item no. HY-13418-10mM
Targets AMPK; TGF-β Receptor; Autophagy
CASRN 1219168-18-9
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
Dorsomorphin (Compound C) dihydrochloride is a potent, selective and ATP-competitive AMPK inhibitor, with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599).
StorageTemperature
4°C (Powder, sealed storage, away from moisture)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
472.41
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 5 mg/mL (ultrasonic)|H2O : 100 mg/mL (ultrasonic)
Manufacturers Target
AMPK; Autophagy; Organoid; TGF-β Receptor
Isoform
ALK2; ALK3; ALK6; AMPK
Pathway
Autophagy; Epigenetics; PI3K/Akt/mTOR; Stem Cell/Wnt; TGF-beta/Smad
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close